blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4192872

EP4192872 - PROTEINS BINDING NKG2D, CD16 AND EGFR [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  09.05.2023
Database last updated on 29.10.2024
FormerThe international publication has been made
Status updated on  11.02.2022
Formerunknown
Status updated on  07.09.2021
Most recent event   Tooltip27.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Dragonfly Therapeutics, Inc.
180 3rd Avenue, Sixth Floor
Waltham, MA 02451 / US
[2024/26]
Former [2023/24]For all designated states
Dragonfly Therapeutics, Inc.
35 Gatehouse Drive
Waltham, MA 02451 / US
Inventor(s)01 / CHEUNG, Ann, F.
Lincoln, MA 01773 / US
02 / DRABIC, Stacey, V.
Cambridge, MA 02140 / US
03 / GRINBERG, Asya
Lexington, MA 02421 / US
04 / JUO, Zong, Sean
Taipei, 114 / TW
05 / LIHARSKA, Katia
Billerica, MA 01821 / US
06 / MORGAN, Christopher, Ryan
Southborough, MA 01772 / US
07 / WAGTMANN, Nicolai
Concord, MA 01742 / US
 [2023/24]
Representative(s)Haseltine Lake Kempner LLP
Cheapside House
138 Cheapside
London EC2V 6BJ / GB
[2023/24]
Application number, filing date21762272.905.08.2021
[2023/24]
WO2021US44737
Priority number, dateUS202063061510P05.08.2020         Original published format: US 202063061510 P
[2023/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022031965
Date:10.02.2022
Language:EN
[2022/06]
Type: A1 Application with search report 
No.:EP4192872
Date:14.06.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2022 takes the place of the publication of the European patent application.
[2023/24]
Search report(s)International search report - published on:EP10.02.2022
ClassificationIPC:C07K16/28, A61P35/00, C07K14/705
[2023/24]
CPC:
C07K16/2863 (EP,IL,US); C07K16/2851 (US); A61P35/00 (EP,IL,US);
C07K16/283 (EP,IL,US); C07K2317/35 (EP,IL); C07K2317/524 (US);
C07K2317/55 (US); C07K2317/565 (US); C07K2317/622 (EP,IL,US);
C07K2317/70 (EP,IL); C07K2317/73 (EP,IL); C07K2317/92 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/24]
Extension statesBA03.03.2023
ME03.03.2023
Validation statesKH03.03.2023
MA03.03.2023
MD03.03.2023
TN03.03.2023
TitleGerman:PROTEINE, DIE NKG2D, CD16 UND EGFR BINDEN[2023/24]
English:PROTEINS BINDING NKG2D, CD16 AND EGFR[2023/24]
French:PROTÉINES SE LIANT À NKG2D, CD16 ET EGFR[2023/24]
Entry into regional phase03.03.2023National basic fee paid 
03.03.2023Designation fee(s) paid 
03.03.2023Examination fee paid 
Examination procedure03.03.2023Amendment by applicant (claims and/or description)
03.03.2023Examination requested  [2023/24]
03.03.2023Date on which the examining division has become responsible
08.05.2023Despatch of a communication from the examining division (Time limit: M04)
18.09.2023Reply to a communication from the examining division
07.11.2024Date of oral proceedings
Fees paidRenewal fee
03.03.2023Renewal fee patent year 03
27.08.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]WO2015184203  (MACROGENICS INC [US]);
 [Y]WO2019035939  (DRAGONFLY THERAPEUTICS INC [US]);
by applicantWO2015095412
 WO2016134371
 WO2018148445
 WO2019157366
 US20090811207
 US20090533709
 US20100875015
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.